Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Paolo
May 22, 2024, 09:09 |
Blog
Paolo Tarantino: Mark your calendars for PER’s 6th Annual Precision Medicine Symposium
Paolo Tarantino made the following post on X: “Mark your calendars for PER’s 6th Annual Precision…
May 20, 2024, 15:03 |
Blog
Paolo Tarantino: Great recap of the randomized trials in the 2L+ HR+ MBC setting by Eva M Ciruelos
Paolo Tarantino shared on X/Twitter: "Great recap of the randomized trials in the 2L+ HR+ MBC…
May 20, 2024, 13:27 |
Blog
Paolo Tarantino: A true honor to join the Executive Scientific Committee of the ENA Triple Meeting 2024
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared a post on LinkedIn…
May 18, 2024, 14:00 |
Blog
Paolo Tarantino: Very promising activity with a new CDK4i
Paolo Tarantino shared the following post by ESMO on X, adding the following: "Very promising…
May 18, 2024, 11:16 |
Blog
Paolo Tarantino: Important point by Erika Hamilton - common questions should derive from RCTs
Paolo Tarantino shared the following post by ESMO on X, adding the following: "Important point…
May 18, 2024, 09:54 |
Societies
Paolo Tarantino: Why was IMpassion132 negative?
Daniel Stover, Medical Oncologist and Computational Biologist at Ohio State University Comprehensive Cancer Center, shared…
May 18, 2024, 08:12 |
Blog
Paolo Tarantino: Sara Tolaney recapitulating 10+ years of de-escalation trials
Paolo Tarantino shared a post on X/Twitter: ''Terrific presentation by Sara Tolaney at ESMO Breast24, recapitulating…
May 18, 2024, 02:12 |
Blog
Paolo Tarantino: Important subanalysis of SOFT/TEXT presented by Otto Metzger
Paolo Tarantino shared on X: "Important subanalysis of SOFT/TEXT presented by Otto Metzger from Dana-Farber’s…
May 16, 2024, 14:13 |
Opinion
Paolo Tarantino: A tremendous opportunity to validate the potential of HER2DX to predict outcomes in HER2+ BC
Paolo Tarantino made the following post on X: “HER2DX to Be Validated in Pivotal ECOG-ACRIN CompassHER2…
May 15, 2024, 12:48 |
Opinion
Paolo Tarantino: Honored to serve as Ambassador for ESMOBreast24!
Paolo Tarantino shared a post by ESMO, on LinkedIn: "Honored to join this outstanding group and…
5
6
7
8
9
All:
264
Posts:
61 - 70
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 3
Small Bowel Cancer: Symptoms & Causes, Types, Diagnosis and Treatment
Mikkael A. Sekeres, Candidate for Secretary of ASH
Paolo Tarantino: Top 10 Breast Cancer abstracts from ESMO2024
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 2
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube